BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3939498)

  • 21. Mupirocin-resistant Staphylococcus aureus.
    Lancet; 1987 Dec; 2(8573):1472-3. PubMed ID: 2892040
    [No Abstract]   [Full Text] [Related]  

  • 22. Bacterial pyoderma in children and therapeutic options including management of community-acquired methicillin resistant Staphylococcus aureus.
    Sardana K; Manchanda V; Rajpal M; Garg VK; Chauhan DS
    Int J Dermatol; 2007 Mar; 46(3):309-13. PubMed ID: 17343593
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical observations and statistical evaluation of the action of a new topical antimicrobial and antimycotic agent in pediatric skin diseases. Polycentric research].
    Allegra F; Cainelli T; Csermely E; Gelmetti C; Gandola M; Martina G; Santini R; Tomasini C; Zanca A
    Minerva Pediatr; 1978 Nov; 30(21):1709-19. PubMed ID: 723817
    [No Abstract]   [Full Text] [Related]  

  • 24. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1987 Jan; 19(1):1-5. PubMed ID: 3104272
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contribution to peroral antibiotic-free and sulfonamide-free therapy of chronic infectious skin disorders of different pathogenesis].
    Giss G
    Z Haut Geschlechtskr; 1965 Oct; 39(7):313-21. PubMed ID: 5893664
    [No Abstract]   [Full Text] [Related]  

  • 26. Pseudomonic acid: a new topical antimicrobial agent.
    Wuite J; Davies BI; Go M; Lambers J; Jackson D; Mellows G
    Lancet; 1983 Aug; 2(8346):394. PubMed ID: 6135884
    [No Abstract]   [Full Text] [Related]  

  • 27. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
    McLinn S
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonic acid--a new antibiotic for skin infections.
    Reilly GD; Spencer RC
    J Antimicrob Chemother; 1984 Mar; 13(3):295-8. PubMed ID: 6427173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
    White DG; Collins PO; Rowsell RB
    J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo.
    Bass JW; Chan DS; Creamer KM; Thompson MW; Malone FJ; Becker TM; Marks SN
    Pediatr Infect Dis J; 1997 Jul; 16(7):708-10. PubMed ID: 9239775
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
    Bork K; Brauers J; Kresken M
    Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Administration of ethonium ointment in treatment of pyoderma in children].
    Kravets' AA; Lipets' ME; Nakonechna NI; Pis'ko GT
    Pediatr Akus Ginekol; 1970; 5():20-1. PubMed ID: 5504842
    [No Abstract]   [Full Text] [Related]  

  • 33. [Staphyloimmunocide in the therapy of chronic ulcerative pyoderma].
    Buchin PI; Dosychev EA; Maslikov VG
    Vestn Dermatol Venerol; 1973 Apr; 47(4):72-5. PubMed ID: 4709917
    [No Abstract]   [Full Text] [Related]  

  • 34. The clinical development of mupirocin.
    Pappa KA
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):873-9. PubMed ID: 2112164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Microbial sensitivity to antibiotics and dioxidine in pyoderma and microbial eczema].
    Artem'ev IuK; Vazhbin LB
    Voen Med Zh; 1983 Dec; (12):64-5. PubMed ID: 6670197
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the treatment of superficial staphylococcal diseases in childhood with Fucidin-gel].
    Staemmler HG; Rodeck H; Linzenmeier G
    Dtsch Med Wochenschr; 1968 Sep; 93(36):1714-6. PubMed ID: 5668265
    [No Abstract]   [Full Text] [Related]  

  • 37. Pseudomonic acid and control of methicillin-resistant staphylococci.
    Casewell MW; Hill RL
    Lancet; 1983 Dec; 2(8362):1312. PubMed ID: 6139659
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyoderma pathophysiology and management.
    Leyden JJ
    Arch Dermatol; 1988 May; 124(5):753-5. PubMed ID: 3129996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections].
    Colin M; Avon P
    Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.